Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Cara Therapeutics, Inc. (CARA) had Return on Equity of -207.61% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$20.97M |
|
$-118.51M |
|
$6.17M |
|
$14.79M |
|
$142.46M |
|
$-121.50M |
|
$2.98M |
|
$-118.51M |
|
$-118.51M |
|
$-118.51M |
|
$-118.51M |
|
$-118.51M |
|
$-118.51M |
|
$-121.50M |
|
$-119.56M |
|
54.15M |
|
54.15M |
|
$-2.19 |
|
$-2.19 |
|
| Balance Sheet Financials | |
$116.16M |
|
$3.32M |
|
$9.69M |
|
$125.84M |
|
$25.59M |
|
-- |
|
$43.17M |
|
$68.76M |
|
$57.09M |
|
$57.09M |
|
$57.09M |
|
54.48M |
|
| Cash Flow Statement Financials | |
$-92.08M |
|
$43.46M |
|
$38.15M |
|
$64.15M |
|
$53.68M |
|
$-10.47M |
|
$13.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
70.56% |
|
-579.43% |
|
-579.43% |
|
-570.21% |
|
-565.21% |
|
-565.21% |
|
$-94.45M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
2.19 |
|
5.22 |
|
69.93 |
|
|
Return on Equity |
-207.61% |
-207.61% |
|
-94.17% |
|
-207.61% |
|
$1.05 |
|
$-1.74 |
|
$-1.70 |
|